跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gemcitabine Sandoz Concentrate for Solution for Infusion 40mg/ml - HSA Drug Approval Details
Approvals
/
HSA
/
Gemcitabine Sandoz Concentrate for Solution for Infusion 40mg/ml
Approved
THERAPEUTIC
Gemcitabine Sandoz Concentrate for Solution for Infusion 40mg/ml
Fareva Unterach GmbH
🇸🇬 Health Sciences Authority
Approval Date
Nov 22, 2013
Approval ID
c5d5282b322cd813
Company
Fareva Unterach GmbH
Type
Therapeutic
Approval Details
Approval Id
c5d5282b322cd813
Drug Name
Gemcitabine Sandoz Concentrate for Solution for Infusion 40mg/ml
Product Name
Gemcitabine Sandoz Concentrate for Solution for Infusion 40mg/ml
Approval Number
SIN14444P
Approval Date
2013-11-22
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Licence Holder
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01BC05
Atc Item Name
gemcitabine
Pharma Manufacturer Name
SANDOZ SINGAPORE PTE. LTD.
Company Detail Path
/organization/sandoz-singapore-pte-ltd
Active Ingredients
Gemcitabine hydrochloride 45.56 mg/ml eqv Gemcitabine
40mg/ml
Gemcitabine hydrochloride 45.56 mg/ml eqv Gemcitabine
40mg/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 22, 2013
Approval ID
c5d5282b322cd813
Type
Therapeutic
Back to HSA Approvals